Case Activity (288)

1. Order | Filed: August 05, 2026 | Entered: August 05, 2026 Astellas Pharma Inc. et al v. Ascent Pharmaceuticals, Inc. et al

   Patent - Abbreviated New Drug Application(ANDA) | Delaware

   Order on Motion for Miscellaneous Relief

   INDICATIVE ORDER: The Court hereby indicates pursuant to Rule 62.1 that if the Federal Circuit remands the case, it will grant a joint motion for relief under Rule 60(b) thereby vacating and modifying the portion of the Final Judgment (D.I. 393 ) precluding the FDA from granting final approval of Ascents ANDA products until after expiration of the infringed patentsleaving all other aspects of the Final Judgment intactwhich is the only remaining obstacle to effectuation of the settlement between the parties, as set forth in the Joint Stipulation and Proposed Order presented by the Parties in connection with their Joint Motion for an Indicative Order. THEREFORE, it is Ordered that the Parties' Joint Motion for Indicative Ruling (D.I. 414 ) is GRANTED.. Signed by Judge Joseph F. Bataillon on 8/5/2026. (mpb)

2. Utility | Filed: August 05, 2026 | Entered: August 05, 2026 Astellas Pharma Inc. et al v. Ascent Pharmaceuticals, Inc. et al

   Patent - Abbreviated New Drug Application(ANDA) | Delaware

   Motions No Longer Referred

   Motions No Longer Referred: 414 Joint MOTION for Indicative Ruling pursuant to Federal Rule of Civil Procedure 62.1 on Joint Motion to Vacate in part and Modify Final Judgment (mpb)

3. 286 additional result(s)